Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide

Semaglutide is a representative of analogues of the incretin hormone human glucagon-like peptide-1 (GLP-1) and is currently used in Russia for the treatment of type 2 diabetes mellitus (T2DM; in monotherapy and in combination therapy), including patients with obesity and overweight.The aim of the wo...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Ametov (Author), I. E. Shokhin (Author), E. A. Rogozhina (Author), T. G. Bodrova (Author), M. E. Nevretdinova (Author), P. A. Bely (Author), K. Ya. Zaslavskaya (Author), V. S. Scherbakova (Author), D. V. Kurkin (Author), K. N. Koryanova (Author), E. S. Mishchenko (Author), E. Yu. Kesova (Author), E. D. Kozlov (Author), E. S. Samoshkina (Author), D. N. Andreev (Author), Yu. G. Kazaishvili (Author), S. M. Noskov (Author), L. A. Balykova (Author)
Format: Book
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2024-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available